Xenetic Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.70

-0.02 (-0.74%)

As of Mar 30, 5:10 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,253.0% upside

Low Target $23.38

Average Target $36.53

High Target $47.42

Current Price $2.70

Current
$2.70

Target
$36.53

$23.38 $36.53 avg $47.42

Scenario Analysis

Bear Case

$23.38

765.9%

Low target

Base Case

$36.53

+1,253.0%

Avg target

Bull Case

$47.42

+1,656.3%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$13.93

-80.6% from high

52-Week Low

$1.90

+42.1% from low

Target vs 52W High

$36.53

+162.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%